Member Info for EmeraldCarrots

Achieve, having been harping on about a profit warning you have dreamed up out of thin air far at least the last two months! What are you you posting for exactly? There are only so many possible reasons.

1. You want the price lower so you can buy some at a lower price? So you want to buy?

2. You have a short position so you will make money the lower the share price is.

3. You have a grudge against Angle Plc and enjoy it when the sp drops?

4. You are insane?

It must be one of the above. Cam you tell everyone why you spend so much tiime doing negative posts. There must be a reason. Please let us know what it is.

Consider getting on board before this train leaves the station and the sp is heading North of 50p.........

Https://clinicaltrials.gov/search?cond=Breast%20Cancer&aggFilters=status:rec%20not

Looking for participants

Not yet recruiting (604)

Recruiting (2,451)

Search Results

Viewing 1-10 out of ******3,055******* studies

LOL! This is JUST Breast cancer................ Anyone interested in HER2?????????????????

The placing in June was @ 15p a share. Now the bid is just 11.5p, 25% lower. We have not had any decent RNS's for over 3 months........ Maybe Newland will be putting one big one, or more out with the interims? With the HER2 assay (developed for delivering the HER2 protein status for Eisai, but owned by Angle) now being advertised on their WEB site it won't be long before there are more new clients. Breast cancer drug trial Plc's have been crying out for the ability to monitor the participants HER2 status just before, during and after the drug trials and that is exactly what Angle can give them......... if they pay. I can’t see how any Company could justify not using Angle’s new service as the information is just what they have wanted for years. As far as I know Angle are THE ONLY COMPANY IN THE WORLD that can do this. They could get swamped with orders if you ask me. All IMHO.

7.18% up now. Another 8% is shorted so that could put the sp up 20 or so %. LOL!

Shorting Co's. Panic is good.......

Shorting Co's having a wobble. Must be something worrying them. Of course any Big Co. oil could snap up Petrofac with ease. Getting an established World wide Company on the cheap..........................

Bid coming???????

The sp is up 4.58% @ 16.15p. Shorting Co's winding down their positions for some reasin. Getting worried? Hitachi??

Won't sign up for Angles new HER2 service for Breast cancer drug trials. They have been crying out for years for a way to test a Breast cancer drug trial participants HER2 status after the initial tumour has been removed and tested. Previously it was nigh on impossible. Now they can. It is a completely obvious massive money spinner for Angle. You will see. This was the start:-

https://www.lse.co.uk/rns/AGL/contract-announcement-with-eisai-inc-49aplx5us0gzg6h.html

Now they can offer the assay to any other Companies as ANGLE OWN THE ASSAY, as it says in the RNS.

Maybe Eisai Inc. insisted the assay would not be offered to other Co's for 6 months as it was only officially launched last week several months after the Eisai Contract was announced.

All IMHO.

Fevertreeman.

You are assuming things like GordonGecko123 has been doing for litrally months spreading fear.

Won't sign up for Angles new HER2 service for Breast cancer drug trials. The likes of TwoGood2Die and GordonGecko123 are either upset because of previous losses on this share or somehow have short positions. They DO KNOW the significance of this new service Angle are now offering. It is very, very significant and will be a huge money earner in the coming months, years, and even decades.

Angle are finally on the cusp of making huge profits. Mark my words.

There is every chance a Pharma Plc will snap them up just to get the Parsortix machine tech and the HER2 assay. The market cap is only £38 million. I would want 50p a share plus as things stand.

All IMHO.

Just about every post you do refers to a profit warning that simply does not exist. My posts are based on the RBS's, if you even read them. Yours are mostly based on "what you think". Great!! LOL!!!

Remember - Angle Plc now offer a HER2 monitoring service for Breast cancer. Fact. Here:-

https://angleplc.com/laboratory-services/her2/

Is it the only Company in the World that offers this sevice??? Answer that one. It is, is it not???

Cancer drug trial Companies. See here:-

https://angleplc.com/laboratory-services/her2/

To me any Company conducting a Breast cancer drug trial who does not employ Angle Plc to obtain this vital HER2 protein status information before, during and after a drug trial is negligent. Total dereliction of duty. Unprofessional.

That is what I think. How on Earth could any responsible professional Company ignore the opportunity to obtain this information which apart from anything else would give them a "running commentary" on how their drug is performing.

All IMHO.

Correction. "drug trials" added. Also "This can be done before, during and after the trial as the results are obtained from a standard blood sample.".

GordonGecko123.

There is no profit warning, you have just invented one in your head to scare people so they sell their shares in Angle Plc. Angle have just last week launched the only assay anywhere in the World that can monitor the HER2 status of participants in Breast cancer **drug trials** by catching an analysing circulating tumour cells. This can be done before, during and after the trial as the results are obtained from a standard blood sample. This follows on from the initial contract with Eisai in January. See:-

https://www.lse.co.uk/rns/AGL/contract-announcement-with-eisai-inc-49aplx5us0gzg6h.html

All IMHO.

GordonGecko123.

There is no profit warning, you have just invented one in your head to scare people so they sell their shares in Angle Plc. Angle have just last week launched the only assay anywhere in the World that can monitor the HER2 status of participants in Breast cancer by catching an analysing circulating tumour cells. This follows on from the initial contract with Eisai in January. See:-

https://www.lse.co.uk/rns/AGL/contract-announcement-with-eisai-inc-49aplx5us0gzg6h.html

All IMHO.

GordonGecko123. As soon as I post there is no profit warning, and you have just dreamed up one based on zero information you get all upset and start calling me names. I read the official RNS's and post about them. So, my posts are based on official information. You on the other hand dream up profit warnings out of thin air because you want shareholders to sell so you can get in on the cheap before the HER2 assay Angle launched last week takes off. Correct?

All IMHO.

GordonGecko123

There you go again. Making things up out of thin air. Based on?? What about sales of the Parsortix machines, at what..... £60K and the consumables? People like you try to scare people into selling so you can buy cheaper by inventing profit warnings that don't exist out of thin air.

All IMHO.

So they only launched the HER2 assay they already are going to use in the Eisai Inc. cancer drug trial last week! The deal with Eisai was RNS's on 2nd Jan 2024. Can only assume the agreement was that Angle (who own the assay, see the RNS) would not market it for 6 months. The assay is worth a shed load, and a very big shed at that if you ask me. Will be interesting to see what other Pharmas doing cancer drug trials decide to use it. There are a load of them.

Https://x.com/parsortix/status/1833057895723806872?s=67&t=BBb2UcjLDTXOFIzJM-vM6A

GordonGecko123.

Looks like your assumed profit warning is built in already?

GordonGecko123.

If the interims come in as expected then I would expect the sp to go back to around the 15p placing level.

That would be 25% gain from the current mid price of 11.75p.

All IMHO.